SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-127438
Filing Date
2023-04-28
Accepted
2023-04-28 16:55:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d428853ddefa14a.htm DEFA14A 11586
2 GRAPHIC g428853g03n03.jpg GRAPHIC 197716
3 GRAPHIC g428853g04n04.jpg GRAPHIC 53799
  Complete submission text file 0001193125-23-127438.txt   347891
Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Filer) CIK: 0001799448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39617 | Film No.: 23867761
SIC: 2836 Biological Products, (No Diagnostic Substances)